Gene Koropowski, WorldNetDaily
Former Alaska Gov. Sarah Palin last year created a nationwide furor when she predicted that ObamaCare would lead to the creation of “death panels” that would decide who would receive life-saving treatments – or be allowed to die.
Now Obama’s health policy team stealthily is moving forward with that idea, WND has learned.
And this development has nothing to do with proposed rules that would have called for doctors to have “end of life” discussions annually with senior citizens. Those plans were dropped from ObamaCare because of public outrage, then slipped into administrative rules, then removed once more in just recent days when the public discovered what was going on.
This new development involves Obama’s political appointees at the powerful Food and Drug Administration, who appear to have started making life or death choices for Americans in 2010 using the cost of a therapy, apparently, as a primary criterion for acceptance or rejection, critics have told WND…
“The FDA denies that cost had anything to do with the ultimate decision against approval,” Greg Conko, a senior fellow who tracks the FDA at the Competitive Enterprise Institute, a free-market think tank in Washington, D.C., told WND.
“But many of us fear that FDA may in fact be slowly but covertly moving in that direction,” he said.
According to statistics released by the FDA on its website, new drug approvals declined dramatically last year. Drugs with the potential to treat cancer and other maladies were not approved by Obama’s regulators for mass marketing. FDA approved a mere 21 new drugs for sale in 2010, down from 25 in 2009.